Name: UMIN ID:
Unique ID issued by UMIN | C000000279 |
---|---|
Receipt number | R000000356 |
Scientific Title | Randomized phase III trial of surgery plus neoadjubant TS-1 and cisplatin compared with surgery alone for type 4 and large type 3 gastric cancer: Japan Clinical Oncology Group Study (JCOG 0501) |
Date of disclosure of the study information | 2005/11/08 |
Last modified on | 2022/08/30 17:50:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/11/08 19:20:28 | ||
2 | Update | 2006/11/25 16:16:04 | Recruitment status |
|
3 | Update | 2007/11/13 19:30:51 | Recruitment status Last follow-up date |
|
4 | Update | 2007/12/14 14:38:37 | Narrative objectives1 Narrative objectives1 |
|
5 | Update | 2007/12/14 14:49:28 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria |
|
6 | Update | 2007/12/14 14:51:21 | Last name of lead principal investigator |
|
7 | Update | 2007/12/14 14:52:38 | Target sample size |
|
8 | Update | 2009/01/23 11:24:11 | Organization Organization Division name Division name Address Address Name of person sending information Name of person sending information Organization Organization Division name Division name TEL |
|
9 | Update | 2009/05/08 11:52:34 | Name of person sending information Name of person sending information |
|
10 | Update | 2009/11/13 17:17:23 | Recruitment status |
|
11 | Update | 2009/11/13 17:21:52 | Institutions |
|
12 | Update | 2011/05/09 11:52:41 | Institutions |
|
13 | Update | 2011/12/02 17:43:34 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
14 | Update | 2012/05/24 16:40:15 | Institutions |
|
15 | Update | 2012/05/31 14:37:57 | Institutions |
|
16 | Update | 2012/06/20 11:55:22 | Acronym |
|
17 | Update | 2013/07/19 17:14:16 | Recruitment status |
|
18 | Update | 2015/02/02 17:33:26 | TEL Division name Division name TEL Institutions |
|
19 | Update | 2015/02/02 17:34:11 | Last follow-up date |
|
20 | Update | 2015/02/03 12:03:58 | Narrative objectives1 Key secondary outcomes |
|
21 | Update | 2015/02/03 12:09:21 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
22 | Update | 2015/05/11 17:43:41 | Institutions |
|
23 | Update | 2016/09/13 11:50:08 | Anticipated trial start date Last follow-up date |
|
24 | Update | 2016/09/13 11:50:39 | Last follow-up date |
|
25 | Update | 2016/09/13 11:52:00 | Name of primary person or sponsor Organization Category of Funding Organization |
|
26 | Update | 2022/08/30 17:50:22 | Recruitment status Date of IRB |